Completed

NCT Number: NCT02368483

Conservative Treatment in Patients With Symptomatic Femoroacetabular Impingement

This is a single-group, prospective, intervention study. A total of 30 participants with unilateral symptomatic femoroacetabular impingement will be included into the study. The intervention consists in neuromuscular training for the lower limb muscles (12 weeks, 2 times/week supervised training, 2 times/week home training). The training includes physical exercises routinely used worldwide in clinical settings. No control intervention group was included into the study because nowadays there is no standard conservative treatment for patients with symptomatic femoroacetabular impingement. Assessments will be performed at (1) baseline, (2) mid-intervention, (3) end-intervention, and (4) follow-up. Clinical, functional, neuromuscular and self-reported parameters will be collected during assessments.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Symptomatic Femoroacetabular Impingement

Age range

18 year–35 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Schulthess Clinic

Zurich, 8008, Switzerland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosis of unilateral symptomatic FAI according to clinical, radiographic and magnetic resonance imaging criteria
Living place: Canton of Zurich or neighbouring Cantons
Signed written informed consent to participate into the study

Exclusion criteria

Previous hip surgery
Any surgery to the lower limbs in the prior 6 months
Congenital/developmental dysplasia
Hip osteoarthritis
Initiation of opioid analgesia and corticosteroid injection for hip pain within the prior 30 days
BMI >35 kg/m2
Significant cardiorespiratory diseases

Treatment and study plan

Neuromuscular Training

Other

Neuromuscular training for the hip and lower limb muscles.The training program is divided into 3 phases, and includes specific exercises for improving the hip range of motion, muscle strength of the hip and lower limb muscles, as well as the trunk stability and coordination. The intervention lasts 12 weeks. Patients will train 2 times/week with a physical therapist and 2 times/weeks alone at home.

Primary outcomes

Hip Function as measured using the Hip Outcome Score questionnaire

Time frame: Change from Baseline in Hip Function at 12 weeks

Hip Function was assessed using the Hip Outcome Score. The Hip Outcome score is a questionnaire used to evaluate hip function during daily and sport activities. Two independent scores are obtained: one for activities of daily living and one for sport activities.

Secondary outcomes

Hip Muscle Strength as measured using dynamometry

Time frame: Change from Baseline in Hip Muscle Strength at 12 weeks

Hip abduction, adduction, internal rotation and external rotation isometric maximal voluntary contraction strength is evaluated with hand-held dynamometry. Hip flexion and extension isometric maximal voluntary contraction strength is evaluated with isokinetic dynamometry.
Movement Control Quality as measured using a visual rating scale

Time frame: Change from Baseline in Movement Control Quality at 12 weeks

Overall body movement pattern quality is visually assessed during the performance of 5 lower extremity functional tests (single-leg squat, lunge, hop lunge, single-leg bridge, single-leg ventral plank).

Sponsors and collaborators

Lead sponsor

Schulthess Klinik

Other

Registry information

Official study title

The Effectiveness of Neuromuscular Training of the Lower Limb Muscles in Reducing the Hip Symptoms in Patients With Symptomatic Femoroacetabular Impingement: a Prospective Intervention Study

Important dates

Study start: 2014
Primary completion: 2017
Study completion: 2017
First posted: Feb 23, 2015
Registry last updated: Jun 18, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.